A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 56,556 shares of ABBV stock, worth $10.2 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
56,556
Previous 45,788 23.52%
Holding current value
$10.2 Million
Previous $7.85 Million 42.21%
% of portfolio
0.46%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $1.76 Million - $2.15 Million
10,768 Added 23.52%
56,556 $11.2 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $462,667 - $540,291
-2,989 Reduced 6.13%
45,788 $7.85 Million
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $517,337 - $589,457
3,237 Added 7.11%
48,777 $8.88 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $135,536 - $152,645
-985 Reduced 2.12%
45,540 $7.06 Million
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $17,233 - $19,949
129 Added 0.28%
46,525 $6.94 Million
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $96,202 - $119,717
726 Added 1.59%
46,396 $6.25 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $1.43 Million - $1.65 Million
9,914 Added 27.73%
45,670 $7.28 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $153,524 - $184,115
1,110 Added 3.2%
35,756 $5.78 Million
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $67,910 - $77,888
-506 Reduced 1.44%
34,646 $4.65 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $110,646 - $140,667
-804 Reduced 2.24%
35,152 $5.38 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $143,990 - $178,651
1,091 Added 3.13%
35,956 $5.83 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $192,729 - $243,858
1,794 Added 5.42%
34,865 $4.72 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $260,467 - $295,669
2,448 Added 7.99%
33,071 $3.57 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $8,311 - $9,259
79 Added 0.26%
30,623 $3.45 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $9,513 - $10,473
93 Added 0.31%
30,544 $3.3 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $189,714 - $256,135
2,357 Added 8.39%
30,451 $3.26 Million
Q3 2020

Oct 20, 2020

BUY
$85.91 - $100.83 $377,918 - $443,551
4,399 Added 18.57%
28,094 $2.46 Million
Q2 2020

Jul 02, 2020

BUY
$73.37 - $98.18 $322,241 - $431,206
4,392 Added 22.75%
23,695 $2.33 Million
Q1 2020

Apr 01, 2020

BUY
$64.5 - $97.79 $17,350 - $26,305
269 Added 1.41%
19,303 $1.47 Million
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $101,847 - $127,433
1,412 Added 8.01%
19,034 $1.69 Million
Q3 2019

Oct 09, 2019

SELL
$62.98 - $75.72 $46,227 - $55,578
-734 Reduced 4.0%
17,622 $1.33 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $103,937 - $132,856
1,582 Added 9.43%
18,356 $1.34 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $250,010 - $294,250
-3,241 Reduced 16.19%
16,774 $1.37 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $118,721 - $146,415
-1,525 Reduced 7.08%
20,015 $1.83 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $2,311 - $2,569
-26 Reduced 0.12%
21,540 $2.03 Million
Q2 2018

Aug 16, 2018

SELL
$89.78 - $106.23 $182,253 - $215,646
-2,030 Reduced 8.6%
21,566 $1.99 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $129,734 - $173,726
-1,410 Reduced 5.64%
23,596 $2.22 Million
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $316,325 - $346,877
3,532 Added 16.45%
25,006 $2.4 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $21,024 - $26,855
301 Added 1.42%
21,474 $1.86 Million
Q2 2017

Aug 15, 2017

BUY
N/A
21,173
21,173 $1.52 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.